Departments
Int'l Cooperation
Research
4th BK21
MERS (Middle East Respiratory Syndrome )
◀ MERS ▶
What is MERS? Middle East Respiratory Syndrome (MERS) is a viral respiratory illness that is new to humans. It was first reported in Saudi Arabia in 2012 and has since spread to several other countries, including the United States. Most people infected with MERS-CoV developed severe acute respiratory illness, including fever, cough, and shortness of breath. About 3-4 out of every 10 patients reported with MERS have died.
Symptoms Most people confirmed to have MERS-CoV infection have had severe acute respiratory illness with symptoms of:
Some people also had gastrointestinal symptoms including diarrhea and nausea/vomiting. For many people with MERS, more severe complications followed, such as pneumonia and kidney failure. Based on information we have to date, the incubation period for MERS (time between when a person is exposed to MERS-CoV and when they start to have symptoms) is usually about 5 or 6 days, but can range from 2-14 days.
Prevention & Treatment Currently, there is no vaccine to prevent MERS-CoV infection. We advise that people help protect themselves from respiratory illnesses by taking everyday preventive actions:
People Who May Be at Increased Risk for MERS
If you have any symptoms of fever, cough or shortness of breath?
http://edition.cnn.com/2015/06/01/world/south-korea-mers/index.html
Office of Graduate School |